3.4. NKX3.1 Overexpression Is Sufficient to Promote Growth During Androgen Depletion and AR-Antagonization in Enzalutamide-Naïve Prostate Cancer Cells and Upregulates Selective Response Element (sARE) Regulated AR Target Genes. This evidence concerns the gene AR and prostate cancer.